DHA esters and use thereof in treatment and prevention of...

Details DHA esters and use thereof in treatment and prevention of... DHA esters and use thereof in treatment and prevention of...

2007-06-22

2011-10-11

Kosar, Andrew D. (Department: 1622)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

C514S277000

Reexamination Certificate

active

08034377

ABSTRACT:
The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.

REFERENCES:
patent: 4619829 (1986-10-01), Motschan
patent: 5760081 (1998-06-01), Leaf et al.
patent: 5919815 (1999-07-01), Bradley et al.
patent: 2003/0050341 (2003-03-01), Bydlon et al.
patent: 2004/0077723 (2004-04-01), Granata et al.
patent: 2005/0171200 (2005-08-01), Calder et al.
patent: 0909183 (2004-08-01), None
patent: 1 157 692 (2005-10-01), None
patent: 1170132 (1969-11-01), None
patent: 59-067263 (1984-04-01), None
patent: 59-067264 (1984-04-01), None
patent: 60-034947 (1985-02-01), None
patent: WO 96/34868 (1996-11-01), None
patent: WO-01/46115 (2001-06-01), None
patent: WO-2004/047835 (2004-06-01), None
patent: WO 2004/091317 (2004-10-01), None
patent: WO-2004/091603 (2004-10-01), None
Tsujita-Kyutoku Miki, et al. “Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: potential mechanisms of action”, Breast Cancer Research. Com [Online] 2004, 6: pp. 291-299.
Tuoya et al. “Apoptosis induction by dohevanil, a DHA substitutive analog of capsaicin, MCF-7 cells”, Life Sciences 78, 2006, pp. 1515-1519.
Harvey D.J., “Picolinyl Derivatives for the Structural Determination of Fatty Acids by Mass Spectrometry: Applications to Polyenoic Acids, Hydroxy Acids, Di-Acids and Related Compounds”, Biomedical Mass Spectrometry 1984 UK, vol. 11, n. 7, 1984, pp. 340-347 XP009078567.
Schmalzing G., et al. “Modulation of ATPase activities of human erthrocyte membranes by free fatty acids or phospholipase A2”, [Medline] J. Member Biology, 1982; 69(1); pp. 65-76.
Swarts H.G., et al., “Binding of unsaturated fatty acids tp NA+, K(+)-ATPase leading to inhibition and inactivation” [Medline] Biochim Biophys Acta. May 9, 1990; 1024(1) pp. 32-40.
Swarts H.G., et al., “Effect of free fatty acids and detergents on H,K-ATPase. The steady-state ATP phosphorylation level and the orientation of the enzyme in membrane preparations” [Medline] Boichim Biophys Acta. Dec. 9, 1991; 1070(2), pp. 283-292.
Benais-Pont G., et al., “ω-3 Polyunsaturated fatty acids and ionizing radiation: combined cytoxicity on human colorectal adenocarcinoma cells”, Nutrition 22 (2006), pp. 1-9.
Torres de Pinedo A., et al., “Efficient lipase-catalyzed synthesis of new lipid antioxidants based on a catechol structure”, Tetrahedron 61 (2005), pp. 7654-7660 XP004971216.
Database CA [online] “3-Pyridylmethyl 4,7,10,13,16,19-docosahexaenoate”, XP002419000, database accession No. 1053, 1985: 487779.
Chung B. H., et al., “Lipolysis-induced partitioning of free fatty acids to lipoproteins: effect on the biological properties of free fatty acids” Journal of Lipid Research, vol. 36, 1956-1970, Copyright 1995 by Lipid Research Inc.
Tsuda Hiroyuki, et al. “Cancer Prevention by Natural. Compounds” Drug Metab. Pharmacokin 19(4), (2004), pp. 245-263.
Maheo Karine, et al., “Differential sensitization of cancer cells to doxorubicin by DHA: A role for lipoperoxidation”, Free Radical Biology & Medicine 39 (2005), pp. 742-751.
Mezoul G., et al. “Enzyme-Catalyzed Synthesis of Aliphatic Polyesters in Organic Media: Study of Transesterification Equilibrium Shift and Characterization of Cyclic Compounds”, Journal of Polymer Science: Part A: Polymer Chemistry, vol. 33, (1995), pp. 2691-2698. XP-002418771.
Definition of B-Vitamin from Wikipedia (http:en.wikipedia.org/wiki/ Vitamin—B).
Definition of Inositol from Wikipedia (http:en.wikipedia.org wiki/Inositol).
Humeau C., et al., “Enzymatic synthesis of fatty acid ascorbyl esters”, Journal of Molecular Catalysis B: Enzymatic 5 (1998), pp. 19-23. XP-002418770.
Bougnoux P., et al., “Diet, Cancer and the Lipidome”, Cancer Epidemiol Biomarkers Prey., 2006; 15(3), Mar. 2006, pp. 416-421.
Kanorskii et al., “Influence of perindopril, rosuvastatin, or omega-3 polyunsaturated fatty acids on efficacy of antirecurrence therapy with sotalol in patients with persistent atrial fibrillation”, Kardiologiia, vol. 47, No. 12 (2007) pp. 39-44.
Saravanan et al., “The Role of Omega-3 Fatty Acids in Primary Prevention of Coronary Artery Disease and in Atrial Fibrillation is Controversial”, Journal of the American College of Cardiology, vol. 55, No. 4 (2010) pp. 410-411.
Saravanan, “Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial”, vol. 3, No. 1 (2009) pp. 46-53.
Attuel et al., “Failure in the Rate Adaptation of the Atrial Refactory Period: Its Relationship to Vulerability”, International Journal of Cardiology, vol. 2, 1982, pp. 179-197, Elsevier Biomedical Press.
Calo et al., “N-3 Fatty Acids for the Prevention of Artial Fibrillation After Coronary Artery Bypass Surgery”, Journal of the American College of Cardiology, vol. 45, No. 10, May 17, 2005, pp. 1723-1728, Elsevier Inc.
O'riordan, “Omego-3 Fatty Acids Prevent Atrial Fibrillation After CABG Surgery,” May 5, 2005, http://www.theheart.org/article/457899.do.
Wijffels et al., “Atrial Fibrillation Begets Atrial Fibrillation: A Study in Awake Chronically Instrumented Goats”, American Heart Association, Circulation, vol. 92, pp. 1954-1968.
Wirth et al., “Atrial Effects of the Novel K+-Channel-Blocker AVE0118 in Anesthnetized Pigs”, Cardiovascular Research, vol. 60, 2003, pp. 298-306, Elsevier B.V.
French Preliminary Search Report and Written Opinion dated Mar. 30, 2011 for Application No. 1056560.

Affiliated with

Also associated with

Rating

DHA esters and use thereof in treatment and prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DHA esters and use thereof in treatment and prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DHA esters and use thereof in treatment and prevention of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4289023